1. Home
  2. ST vs FOLD Comparison

ST vs FOLD Comparison

Compare ST & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ST
  • FOLD
  • Stock Information
  • Founded
  • ST 1916
  • FOLD 2002
  • Country
  • ST United States
  • FOLD United States
  • Employees
  • ST N/A
  • FOLD N/A
  • Industry
  • ST Industrial Machinery/Components
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ST Industrials
  • FOLD Health Care
  • Exchange
  • ST Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • ST 3.1B
  • FOLD 2.9B
  • IPO Year
  • ST 2010
  • FOLD 2007
  • Fundamental
  • Price
  • ST $26.07
  • FOLD $6.10
  • Analyst Decision
  • ST Buy
  • FOLD Buy
  • Analyst Count
  • ST 13
  • FOLD 10
  • Target Price
  • ST $34.08
  • FOLD $16.22
  • AVG Volume (30 Days)
  • ST 1.8M
  • FOLD 5.3M
  • Earning Date
  • ST 05-08-2025
  • FOLD 05-01-2025
  • Dividend Yield
  • ST 1.84%
  • FOLD N/A
  • EPS Growth
  • ST N/A
  • FOLD N/A
  • EPS
  • ST 0.82
  • FOLD N/A
  • Revenue
  • ST $3,837,310,000.00
  • FOLD $543,141,000.00
  • Revenue This Year
  • ST N/A
  • FOLD $19.85
  • Revenue Next Year
  • ST $4.31
  • FOLD $23.50
  • P/E Ratio
  • ST $31.93
  • FOLD N/A
  • Revenue Growth
  • ST N/A
  • FOLD 28.25
  • 52 Week Low
  • ST $17.32
  • FOLD $5.81
  • 52 Week High
  • ST $42.33
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • ST 56.72
  • FOLD 39.70
  • Support Level
  • ST $24.69
  • FOLD $6.05
  • Resistance Level
  • ST $27.40
  • FOLD $6.37
  • Average True Range (ATR)
  • ST 0.78
  • FOLD 0.24
  • MACD
  • ST -0.04
  • FOLD 0.04
  • Stochastic Oscillator
  • ST 33.87
  • FOLD 33.51

About ST Sensata Technologies Holding plc

Sensata Technologies is a global supplier of sensors for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: